MR编号 | NL/H/3938/001 |
---|
药品名称 | Bortezomib CF 2,5 mg/ml, solution for injection |
---|
活性成分 | |
---|
剂型 | Solution for injection |
---|
上市许可持有人 | Centrafarm B.V.
Breda
4814 NE
Nederland |
---|
参考成员国 - 产品名称 | Netherlands (NL) Bortezomib CF 2,5 mg/ml, oplossing voor injectie |
---|
互认成员国 - 产品名称 | - Iceland (IS)
- Portugal (PT)
- United Kingdom (Northern Ireland) (XI)
- Hungary (HU)
BORTEZOMIB STADA 2,5 mg/ml oldatos injekció - Romania (RO)
Bortezomib Stada 2,5 mg/ml soluţie injectabilă - Norway (NO)
- Cyprus (CY)
Bortezomib/STADA - Estonia (EE)
- Greece (GR)
- Latvia (LV)
Bortezomib Stada 2,5 mg/ml šķīdums injekcijām - Malta (MT)
Bortezomib Clonmel 2.5mg/ml Solution for Injection - Germany (DE)
- Denmark (DK)
Bortezomib Stada - Belgium (BE)
Bortezomib EG 2,5 mg/ml oplossing voor injectie - Luxembourg (LU)
- Ireland (IE)
- Austria (AT)
Bortezomib STADA 2,5 mg/ml Injektionslösung - France (FR)
- Spain (ES)
- Italy (IT)
- Sweden (SE)
- Finland (FI)
- Slovakia (SK)
- Lithuania (LT)
Bortezomib STADA 2,5 mg/ml injekcinis tirpalas
|
---|
许可日期 | 2018/01/25 |
---|
最近更新日期 | 2024/12/24 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Abridged
- TypeLevel2:Initial Application
- TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|